Back to search

Article

Most azole antifungal resistance mutations in the drug target provide cross-resistance and carry no intrinsic fitness cost

2023-12-14

Abstract excerpt

Azole antifungals are among the most frequently used drugs to treat fungal infections. Amino acid substitutions in and around the binding site of the azole target Erg11 (Cyp51) are a common resistance mechanism in pathogenic yeasts such as Candida albicans . How many and which mutations confer resistance, and at what cost, is however largely unknown. Here, we measure the impact of nearly 4,000 amino acid variants...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
89d98c96-e24e-53ac-abe0-98f2a935a14f
DOI
10.1101/2023.12.13.571438
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Most azole antifungal resistance mutations in the drug target provide cross-resistance and carry no intrinsic fitness costDOI 10.1101/2023.12.13.571438
Select a neighboring publication to make it the new centre.